The Central-European SentiMag study: Sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope

被引:151
作者
Thill, Marc [1 ]
Kurylcio, Andrzej [2 ]
Welter, Rebekka [3 ]
van Haasteren, Viviana [1 ]
Grosse, Britta [1 ]
Berclaz, Gilles [4 ]
Polkowski, Wojciech [2 ]
Hauser, Nik [3 ]
机构
[1] Agaples Markus Hosp, Dept Gynecol & Obstet, Breast Canc Ctr, D-60431 Frankfurt, Germany
[2] Med Univ Lublin, Dept Surg Oncol, Lublin, Poland
[3] Kantonsspital Baden, Interdisciplinary Breast Ctr, Dept Gynecol & Obstet, Baden, Switzerland
[4] Engeriedspital, Breast Ctr Bern, Lindenhofgrp, Bern, Switzerland
关键词
Invasive breast cancer; Sentinel lymph node biopsy; Superparamagnetic iron oxide (SPIO); SentiMag (R); Sienna plus (R); BREAST-CANCER PATIENTS; INDOCYANINE GREEN; FLUORESCENCE; TRIAL; BLUE;
D O I
10.1016/j.breast.2014.01.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sentinel lymph node biopsy (SLNB) is the standard surgical procedure for the axilla in early node-negative breast cancer. To date, the "gold standard" to localize the sentinel lymph node (SLN) is the radiotracer(99m)Tc with or without blue dye. The aim of this study was to evaluate potential equivalency of the new SentiMag (R) technique in comparison to the "gold standard". Within this prospective, multicentric and multinational non-inferiority study including 150 patients Tc-99m was compared with the magnetic technique, using superparamagnetic iron oxide particles (SPIOs, Sienna+(R)) for localization of SLNs. The results showed a detection rate per patient of 97.3% (146/150) for Tc-99m vs. 98.0% (147/150) for Sienna+(R) with a similar average number of removed SLNs per patient and a higher per patient malignancy detection rate for the SPIO tracer. We obtained convincing results that magnetic SLNB can be performed easily, safely and equivalently well in comparison to the radiotracer method. (C) 2014 The Authors. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:175 / 179
页数:5
相关论文
共 25 条
[1]  
[Anonymous], ANN SURG
[2]   Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green [J].
Aoyama, Kei ;
Kamio, Takako ;
Ohchi, Tetsuya ;
Nishizawa, Masako ;
Kameoka, Shingo .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2011, 9
[3]   Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience [J].
Barthelmes, L. ;
Goyal, A. ;
Newcombe, R. G. ;
McNeill, F. ;
Mansel, R. E. .
EJSO, 2010, 36 (04) :399-403
[4]   Factors predicting failure to identify a sentinel lymph node in breast cancer [J].
Chagpar, AB ;
Martin, RC ;
Scoggins, CR ;
Carlson, DJ ;
Laidley, AL ;
El-Eid, SE ;
McGlothin, TQ ;
Noyes, RD ;
Ley, PB ;
Tuttle, TM ;
McMasters, KM .
SURGERY, 2005, 138 (01) :56-63
[5]   Factors of importance for scintigraphic non-visualisation of sentinel nodes in breast cancer [J].
Chakera, AH ;
Friis, E ;
Hesse, U ;
Al-Suliman, N ;
Zerahn, B ;
Hesse, B .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (03) :286-293
[6]  
Douek M, 2013, EUR J SURG ONCOL, V39, pS85, DOI [10.1016/j.ejso.2013.07.124, DOI 10.1016/J.EJSO.2013.07.124]
[7]   LYMPHATIC MAPPING AND SENTINEL LYMPHADENECTOMY FOR BREAST-CANCER [J].
GIULIANO, AE ;
KIRGAN, DM ;
GUENTHER, JM ;
MORTON, DL .
ANNALS OF SURGERY, 1994, 220 (03) :391-401
[8]   Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer [J].
Hojo, Takashi ;
Nagao, Tomoya ;
Kikuyama, Mizuho ;
Akashi, Sadako ;
Kinoshita, Takayuki .
BREAST, 2010, 19 (03) :210-213
[9]  
Joshi TP, 2007, EUR J SURG ONCOL, V33, P1135
[10]   SURGICAL RESECTION AND RADIOLOCALIZATION OF THE SENTINEL LYMPH-NODE IN BREAST-CANCER USING A GAMMA-PROBE [J].
KRAG, DN ;
WEAVER, DL ;
ALEX, JC ;
FAIRBANK, JT .
SURGICAL ONCOLOGY-OXFORD, 1993, 2 (06) :335-340